Risk of elevated resting heart rate on the development of type 2 diabetes in patients with clinically manifest vascular diseases.
暂无分享,去创建一个
[1] Hajime Uno,et al. Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease. , 2011, The American journal of cardiology.
[2] H. Krum,et al. Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension: A Pilot Study , 2011, Circulation.
[3] P. Palatini,et al. Resting Heart Rate as a Predictor of Body Weight Gain in the Early Stage of Hypertension , 2011, Obesity.
[4] S. Stocker,et al. Sympathetic Response to Insulin Is Mediated by Melanocortin 3/4 Receptors in the Hypothalamic Paraventricular Nucleus , 2011, Hypertension.
[5] X. Shu,et al. Resting heart rate and risk of type 2 diabetes in women. , 2010, International journal of epidemiology.
[6] D. Waters,et al. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial). , 2010, The American journal of cardiology.
[7] M. Kawai,et al. Resting heart rate and blood pressure, independent of each other, proportionally raise the risk for type-2 diabetes mellitus. , 2010, International journal of epidemiology.
[8] S. Gough,et al. Impact of obesity and type 2 diabetes on health-related quality of life in the general population in England , 2009, Diabetes, metabolic syndrome and obesity : targets and therapy.
[9] A. Esteghamati,et al. Association of serum leptin levels with homeostasis model assessment-estimated insulin resistance and metabolic syndrome: the key role of central obesity. , 2009, Metabolic syndrome and related disorders.
[10] T. Imaizumi,et al. Higher Heart Rate May Predispose to Obesity and Diabetes Mellitus: 20-Year Prospective Study in a General Population , 2009 .
[11] F. Pieruzzi,et al. Sympathetic activation in cardiovascular and renal disease. , 2009, Journal of nephrology.
[12] Elisabeth Lambert,et al. Mechanisms of sympathetic activation in obesity-related hypertension. , 2006, Hypertension.
[13] Mark E Molitch,et al. The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. , 2006, Diabetes care.
[14] Edoardo Cervoni. Impact of obesity. , 2005, The British journal of general practice : the journal of the Royal College of General Practitioners.
[15] G. Mancia,et al. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives , 2004, Journal of hypertension.
[16] S. Julius,et al. Elevated Heart Rate: A Major Risk Factor for Cardiovascular Disease , 2004, Clinical and experimental hypertension.
[17] A. Folsom,et al. Prospective Investigation of Autonomic Nervous System Function and the Development of Type 2 Diabetes: The Atherosclerosis Risk In Communities Study, 1987–1998 , 2003, Circulation.
[18] L. Eberly,et al. Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience. , 2003, Diabetes care.
[19] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.
[20] V. Somers,et al. Leptin interacts with heart rate but not sympathetic nerve traffic in healthy male subjects , 2001, Journal of hypertension.
[21] B. Howard,et al. Diabetes and cardiovascular disease , 2000, Annual review of medicine.
[22] K. Nonogaki,et al. New insights into sympathetic regulation of glucose and fat metabolism , 2000, Diabetologia.
[23] A. Algra,et al. Second Manifestations of ARTerial disease (SMART) study: Rationale and design , 1999, European Journal of Epidemiology.
[24] G Mancia,et al. Heart rate as marker of sympathetic activity , 1998, Journal of hypertension.
[25] J. Ivy. Role of Exercise Training in the Prevention and Treatment of Insulin Resistance and Non-Insulin-Dependent Diabetes Mellitus , 1997, Sports medicine.
[26] G. Reaven,et al. Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. , 1996, The New England journal of medicine.
[27] Rene Devos,et al. Identification and expression cloning of a leptin receptor, OB-R , 1995, Cell.
[28] M. Stern. Diabetes and Cardiovascular Disease: The “Common Soil” Hypothesis , 1995, Diabetes.
[29] S. Julius,et al. Reflex sympathetic activation induces acute insulin resistance in the human forearm. , 1993, Hypertension.
[30] E A Anderson,et al. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. , 1991, The Journal of clinical investigation.
[31] J. D. Etlinger,et al. Slow to fast alterations in skeletal muscle fibers caused by clenbuterol, a beta 2-receptor agonist. , 1988, The American journal of physiology.
[32] A. Sauter,et al. Effect of insulin on central catecholamines , 1983, Brain Research.
[33] R. DeFronzo,et al. Epinephrine-induced insulin resistance in man. , 1980, The Journal of clinical investigation.
[34] D L McGee,et al. Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study , 1979, Diabetes Care.
[35] C. G. Blomqvist,et al. Cardiovascular adaptations to physical training. , 1977, Annual review of physiology.
[36] J. Dungan. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study , 2011 .
[37] D. Jacobs,et al. Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. , 2007, Epidemiologic reviews.
[38] J. Hall,et al. Chronic leptin infusion increases arterial pressure. , 1998, Hypertension.
[39] T. Ogihara,et al. Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. , 1997, American journal of hypertension.
[40] T. Shimazu. Innervation of the liver and glucoregulation: roles of the hypothalamus and autonomic nerves. , 1996, Nutrition.
[41] S. Julius,et al. The interconnection between sympathetics, microcirculation, and insulin resistance in hypertension. , 1992, Blood pressure.